New drug aims to reduce Blood-Letting in rare blood cancer
NCT ID NCT05499013
First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tests an experimental drug called SLN124 in 69 adults with polycythemia vera, a condition where the body makes too many red blood cells. The goal is to see if SLN124 can safely reduce the need for phlebotomies (blood removal) and help control blood counts. The trial has two parts: first, an open-label phase to find the right dose, then a double-blind phase where some patients get the drug and others get a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Linear Clinical Research
Nedlands, Australia
-
Research Site
Hammond, Louisiana, 70403, United States
-
Research Site
Buffalo, New York, 14203, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Huntsville, Texas, 77340, United States
-
Research Site
Benowa, Australia
-
Research Site
Hobart, Australia
-
Research Site
Kurralta Park, Australia
-
Research Site
Melbourne, Australia
-
Research Site
Richmond, Australia
-
Research Site
Plovdiv, Bulgaria
-
Research Site
Toronto, Canada
-
Research Site
Freiburg im Breisgau, Germany
-
Research Site
Hanover, Germany
-
Research Site
Alessandria, Italy
-
Research Site
Meldola, Italy
-
Research Site
Johor Bahru, Malaysia
-
Research Site
Kuala Terengganu, Malaysia
-
Research Site
Kuantan, Malaysia
-
Research Site
Kuching, Malaysia
-
Research Site
Gdansk, Poland
-
Research Site
Katowice, Poland
-
Research Site
Lublin, Poland
-
Research Site
Barcelona, Spain
-
Research Site
Madrid, Spain
-
Research Site 2
Melbourne, Australia
-
Research Site 2
Plovdiv, Bulgaria
Conditions
Explore the condition pages connected to this study.